# ACORN CAPITAL ADVISORS, LLC: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 2054410.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $366.5m
- Positions: 20 (20 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2054410/000163658726000067/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [CG ONCOLOGY INC (CGON)](/companies/cgon.md) | COM | $80.4m | 21.9% | 1,131,500 |  | Added +999 |
| UROGEN PHARMA LTD | COM | $61.6m | 16.8% | 1,673,420 |  | Unchanged |
| [TREVI THERAPEUTICS INC (TRVI)](/companies/trvi.md) | COM | $40.0m | 10.9% | 2,144,844 |  | Unchanged |
| [CANDEL THERAPEUTICS INC (CADL)](/companies/cadl.md) | COM | $36.0m | 9.8% | 3,497,948 |  | Unchanged |
| [PUMA BIOTECHNOLOGY INC (PBYI)](/companies/pbyi.md) | COM | $33.5m | 9.1% | 4,131,299 |  | Unchanged |
| [JADE BIOSCEINCES INC (JBIO)](/companies/jbio.md) | COM NEW | $21.9m | 6.0% | 986,760 |  | Added +200,000 |
| [BICARA THERAPEUTICS (BCAX)](/companies/bcax.md) | COM | $19.1m | 5.2% | 643,381 |  | Reduced −1 |
| [KARYOPHARM THERAPEUTICS INC (KPTI)](/companies/kpti.md) | COMMON STOCK | $14.8m | 4.0% | 1,518,113 |  | Added +1,230,287 |
| [ONKURE THERAPEUTICS INC (OKUR)](/companies/okur.md) | CLASS A COM | $12.9m | 3.5% | 2,839,674 |  | Unchanged |
| HELUS PHARMA INC. | COM STK | $10.2m | 2.8% | 1,540,266 |  | Unchanged |
| [PROTARA THERAPEUTICS INC (TARA)](/companies/tara.md) | COM STK | $6.7m | 1.8% | 1,752,115 |  | Unchanged |
| [AURA BIOSCIENCES INC (AURA)](/companies/aura.md) | COM | $6.6m | 1.8% | 929,077 |  | Added +333,333 |
| [LEONABIO, INC. (LONA)](/companies/lona.md) | COMMON STOCK | $5.8m | 1.6% | 634,539 |  | Unchanged |
| [VERASTEM INC (VSTM)](/companies/vstm.md) | COM | $5.6m | 1.5% | 1,469,153 |  | Unchanged |
| [WHITEHAWK THERAPEUTICS INC (WHWK)](/companies/whwk.md) | COM | $5.2m | 1.4% | 1,139,363 |  | Unchanged |
| [Q32 BIO INC. (QTTB)](/companies/qttb.md) | COM | $2.8m | 0.8% | 216,171 |  | Reduced −98,881 |
| [EUGENE THERAPEUTICS (ENGN)](/companies/engn.md) | COM | $2.2m | 0.6% | 1,271,257 |  | New +1,271,257 |
| [JASPER THERAPEUTICS (JSPR)](/companies/jspr.md) | COM | $604.0k | 0.2% | 1,438,159 |  | Added +26,667 |
| BIOATLA INC | COM | $447.6k | 0.1% | 108,126 |  | Reduced −5,298,219 |
| VYNE THERAPEUTICS INC | COM | $926 | <0.1% | 1,425 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [CARDIF ONCOLOGY  INC (CRDF)](/companies/crdf.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,762,084 |
| TERNS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −1,746,264 |
| X4 PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −234,039 |

Source: SEC EDGAR, Form 13F-HR, accession 0001636587-26-000067. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.